News & Announcements

Dr. James Kochenderfer FNIH Trailblazer Prize

Dr. Kochenderfer received the Trailblazer Prize and a $10,000 honorarium for pioneering the development of immunotherapies that leverage chimeric antigen receptor (CAR) T-cells to treat blood cancers.

FNIH Friends of Patients at NIH Partnership for Patients

The Partnership was created to leverage one another’s competence and infrastructure to ensure that patients in need at the NIH Clinical Center receive support to participate in groundbreaking and potentially life-saving treatments.

Chemotherapeutic Impact on the Immune MicroEnvironment

The project will use a cutting-edge technology to analyze metastatic breast cancer samples which will help scientists understand what changes caused by chemotherapy alter the immune microenvironment, and therefore a patient’s response to immunotherapies.


Kidney Safety

FNIH Biomarkers Consortium and Critical Path Institute achieve the first ever qualification of a clinical safety biomarker by the U.S. Food and Drug Administration.

AMP-AD video

The AMP-AD partnership and its Knowledge Portal are crucial to advancing research on the treatment and detection of Alzheimer's.

2019 NonProfit Pro Executive of the Year

FNIH President and Executive Director, Dr. Maria Freire, was recently named NonProfit Pro's 2019 Executive of the Year!




Front Page: